Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ChaK1(h) Kinase panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of human CHAK1 at 1000 nM by KINOMEscan assay relative to control
SummaryPubMed CitationRelated BioAssays by Target
ChaK1(h) Eurofins kinase panel
ChaK1(h) Eurofins Kinase panel
ChaK1(h) Millipore kinase panel
Inhibition of recombinant human CHAK1 (1180 to end residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Inhibition of TRPM7 in NHLF assessed as inhibition of TGFB1-induced FMT by measuring alpha-SMA expression at 25 to 50 uM incubated for 24 hrs by Western blot analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of recombinant human CHAK1 (1180 to end residues) at 1 uM using myelin ba as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control
Inhibition of TRPM7 (unknown origin) at 1 uM relative to control
Inhibition of recombinant human CHAK1 (1180 to end residues) using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis
Inhibition of recombinant human CHAK1 (1180 to end residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control
Inhibition of human TRPM7 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay
Inhibition of recombinant human CHAK1 (1180 to end residues) at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method
Inhibition of recombinant human CHAK1 (1180 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control
Assay data:2 Tested
Inhibition of recombinant human CHAK1 (1180 to end residues) assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Inhibition of recombinant human ChaK1 (1180 to end residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method
Human TRPM7 (ChaK subfamily)
Assay data:4 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Primary screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:91 Active, 714 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on